Literature DB >> 3672667

ABH isoantigens, histology and DNA ploidy in 36 consecutive patients with transitional cell bladder cancer. Status of tumor and biopsies taken from visually normal urothelium.

E Borgström1, C Nyman, M Lönn.   

Abstract

Tumors and biopsies from visibly normal urothelium in 36 consecutive patients with transitional cell bladder carcinoma were analysed for histological pathology, DNA ploidy and ABH isoantigens. Tumor isoantigen deletion correlated strongly with malignant histology (p = 0.016) and aneuploidy (p = 0.005). In 4/12 patients with ABH isoantigens present on the tumor, and in 6/8 with isoantigens absent, isoantigen changes were found in normal looking urothelium, usually with normal histology and ploidy. It was concluded that the ABH isoantigen change was an early event in bladder carcinoma.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3672667     DOI: 10.1007/bf00262099

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  16 in total

1.  Enzymic conversion of "H1-glycolipid" to A or B-glycolipid and deficiency of these enzyme activities in adenocarcinoma.

Authors:  K Stellner; S Hakomori; G S Warner
Journal:  Biochem Biophys Res Commun       Date:  1973-11-16       Impact factor: 3.575

2.  Early immunologic diagnosis and prognosis of carcinoma. Philip Levine Award Address.

Authors:  I Davidsohn
Journal:  Am J Clin Pathol       Date:  1972-06       Impact factor: 2.493

Review 3.  Tissue blood group ABH and Thomsen-Friedenreich antigens in human urinary bladder carcinoma.

Authors:  R S Weinstein; A W Miller; J S Coon
Journal:  Prog Clin Biol Res       Date:  1984

4.  Expression of blood-group-related antigens in carcinoma in situ of the urinary bladder.

Authors:  J S Coon; A McCall; A W Miller; G M Farrow; R S Weinstein
Journal:  Cancer       Date:  1985-08-15       Impact factor: 6.860

5.  Immunologic relationship between blood group substances and a fucose-containing glycolipid of human adenocarcinoma.

Authors:  S I Hakomori; J Koscielak; K J Bloch; R W Jeanloz
Journal:  J Immunol       Date:  1967-01       Impact factor: 5.422

6.  Clinical significance of A, B, H isoantigen deletion of urothelial cells in bladder carcinoma.

Authors:  E Borgström; B Wahren
Journal:  Cancer       Date:  1986-12-01       Impact factor: 6.860

7.  Fluorescence microscopy: reduced photobleaching of rhodamine and fluorescein protein conjugates by n-propyl gallate.

Authors:  H Giloh; J W Sedat
Journal:  Science       Date:  1982-09-24       Impact factor: 47.728

8.  Specific red cell adherence: immunologic evaluation of random mucosal biopsies in carcinoma of the bladder.

Authors:  B S Stein; J M Reyes; R O Petersen; D McNellis; A R Kendall
Journal:  J Urol       Date:  1981-07       Impact factor: 7.450

9.  Blood group precursor T-antigen expression in human urinary bladder carcinoma.

Authors:  J S Coon; R S Weinstein; J L Summers
Journal:  Am J Clin Pathol       Date:  1982-06       Impact factor: 2.493

10.  Blood group isoantigen deletion in carcinoma in situ of the urinary bladder.

Authors:  R S Weinstein; J Alroy; G M Farrow; A W Miller; I Davidsohn
Journal:  Cancer       Date:  1979-02       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.